Cardlytics (CDLX) Tops Q2 EPS by 31c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.15), $0.31 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $69.64 million versus the consensus estimate of $75.39 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Meta CEO Mark Zuckerberg Says In Internal Town Hall That Ai Agent Development Over The Last Four Months Hasn't 'accelerated In The Way We Expected' - Reuters
• DAP Introduces Gaps & Cracks High Density Foam with HydroAction Polyurethane
• SAI.TECH (SAI) files $300M mixed shelf